Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Kyntra Bio Inc (KYNB)

Kyntra Bio Inc (KYNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Financial Summary for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Kyntra Bio is a biopharmaceutical company focused on development of novel therapies in oncology and rare disease. Kyntra Bio, formerly known as FibroGen Inc., is based in SAN FRANCISCO.

Fiscal Year End Date: 12/31

Income Statement

(Values in U.S. Thousands) Dec, 2025 Dec, 2024 Dec, 2023 Dec, 2022 Dec, 2021
Sales 6,440 29,620 147,750 140,730 235,310
Sales Growth -78.26% -79.95% +4.99% -40.19% +33.46%
Net Income 183,450 -47,580 -284,230 -293,650 -290,020
Net Income Growth +485.56% +83.26% +3.21% -1.25% -53.21%

Balance Sheet

(Values in U.S. Thousands) Dec, 2025 Dec, 2024 Dec, 2023 Dec, 2022 Dec, 2021
Total Assets 119,590 214,530 423,530 610,090 773,820
Total Assets Growth -44.25% -49.35% -30.58% -21.16% -6.41%
Total Liabilities 136,600 419,640 607,210 611,570 544,710
Total Liabilities Growth -67.45% -30.89% -0.71% +12.27% +41.34%

Cash Flow

(Values in U.S. Thousands) Dec, 2025 Dec, 2024 Dec, 2023 Dec, 2022 Dec, 2021
Operating Cash Flow -4,770 -138,000 -315,020 -145,930 -82,230
Operating Cash Flow Growth +96.54% +56.19% -115.87% -77.47% -200.77%
Net Cash Flow -54,310 -11,510 -42,010 -15,520 -507,170
Change in Net Cash Flow -371.85% +72.60% -170.68% +96.94% -191.86%
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.